Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

Share Price is delayed by 15 minutes
Get Live Data
407.00    0.80 (0.20%)
Bid:
405.00
Ask:
405.40
Spread: 0.40 (0.099%)
Market Cap: £613.40m
CBG Live PriceLast checked at - London Stock Exchange

Intraday Close Bros Share Chart

Scheduled Trading Update

22 Jan 2019 07:00

RNS Number : 6874N
Close Brothers Group PLC
22 January 2019
 

 

Scheduled Trading Update

Close Brothers Group plc ("the group" or "Close Brothers") today issues its scheduled pre-close trading update ahead of its 2019 half year end. Close Brothers will be releasing its half year results for the six months ending 31 January 2019 on 12 March 2019.

All statements in this release relate to continuing operations1 over the five months to 31 December 2018 unless otherwise indicated.

Group and divisional performance

The group has achieved a solid performance overall, notwithstanding the difficult trading conditions for our market facing businesses.

The Banking division has continued to perform well and in line with expectations, as we focus on maintaining our disciplined approach to lending and investing to maximise the long-term potential of our businesses.

The loan book grew 3.1% in the period to £7.5 billion (1 August 2018: £7.2 billion2), driven by good new business volumes across the Commercial businesses and in Premium Finance.

Impairment charges remained low, with strong credit performance across all businesses. The net interest margin has remained broadly stable since the last financial year, reflecting our continued pricing discipline.

Winterflood has continued to deliver solid profitability, but volumes and trading income have been significantly lower than the prior year reflecting difficult and volatile equity market conditions, particularly in December.

Asset Management has continued to achieve good net inflows, although these were more than offset by negative market movements, resulting in a 3% decline in managed assets to £10.0 billion at 31 December 2018 (31 July 2018: £10.4 billion) and a decrease in total client assets to £11.7 billion (31 July 2018: £12.2 billion).

Outlook

Overall, we expect a solid outcome for the first half, and remain well positioned for the remainder of the financial year.

 

1 Results from continuing operations exclude the unsecured retail point of sale finance business, which was classified as a discontinued operation in the group's 2018 financial statements.

2 The opening net loan book of £7,239 million reflects the adoption of IFRS 9 at 1 August 2018. For further details see the group's IFRS 9 transition document published on 7 November 2018.

 

 

Enquiries

 

Sophie Gillingham

Close Brothers Group plc

020 7655 3844

Matt Bullivant

Close Brothers Group plc

020 7655 3698

Declan Simpson

Close Brothers Group plc

020 7655 3632

Andy Donald

Maitland

020 7379 5151

 

About Close Brothers

Close Brothers is a leading UK merchant banking group providing lending, deposit taking, wealth management services and securities trading. We employ around 3,300 people, principally in the UK. Close Brothers Group plc is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKDDPABKDNDB
Date   Source Headline
20th Apr 20201:55 pmRNSHolding(s) in Company
15th Apr 20202:05 pmRNSHolding(s) in Company
8th Apr 20205:23 pmRNSDirector/PDMR Shareholding
7th Apr 20203:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20207:00 amRNSUpdate on Dividend Payments
16th Mar 20202:00 pmRNSTransaction in Own Shares
11th Mar 202010:53 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNSHalf-year Report
9th Mar 20202:00 pmRNSTransaction in Own Shares
6th Mar 202010:27 amRNSDirector/PDMR Shareholding
2nd Mar 20202:00 pmRNSTransaction in Own Shares
28th Feb 202011:56 amRNSTotal Voting Rights
24th Feb 20202:00 pmRNSTransaction in Own Shares
20th Feb 202012:56 pmRNSHolding(s) in Company
17th Feb 20202:00 pmRNSTransaction in Own Shares
10th Feb 20202:00 pmRNSTransaction in Own Shares
6th Feb 202011:26 amRNSDirector/PDMR Shareholding
3rd Feb 20202:00 pmRNSTransaction in Own Shares
31st Jan 20203:14 pmRNSTotal Voting Rights
27th Jan 20201:00 pmRNSTransaction in Own Shares
22nd Jan 20207:00 amRNSScheduled Trading Update
20th Jan 20202:00 pmRNSTransaction in Own Shares
13th Jan 20202:00 pmRNSTransaction in Own Shares
7th Jan 20205:20 pmRNSHolding(s) in Company
7th Jan 202011:38 amRNSDirector/PDMR Shareholding
6th Jan 20202:40 pmRNSDirector/PDMR Shareholding
6th Jan 20202:38 pmRNSTransaction in Own Shares
31st Dec 201910:26 amRNSTotal Voting Rights
23rd Dec 20192:00 pmRNSTransaction in Own Shares
20th Dec 201912:19 pmRNSDirector/PDMR Shareholding
18th Dec 201912:37 pmRNSNotice of Pre-Close Trading Update
16th Dec 20192:00 pmRNSTransaction in Own Shares
16th Dec 201912:16 pmRNSDirectorate Change
9th Dec 20192:30 pmRNSDirector/PDMR Shareholding
9th Dec 20192:00 pmRNSTransaction in Own Shares
6th Dec 20194:06 pmRNSDirector/PDMR Shareholding
5th Dec 201912:29 pmRNSDirector/PDMR Shareholding
2nd Dec 20192:00 pmRNSTransaction in Own Shares
29th Nov 20193:24 pmRNSDirector/PDMR Shareholding
29th Nov 20193:06 pmRNSTotal Voting Rights
27th Nov 201912:47 pmRNSDirector/PDMR Shareholding
25th Nov 20192:00 pmRNSTransaction in Own Shares
25th Nov 201912:26 pmRNSDirector/PDMR Shareholding
21st Nov 20195:12 pmRNSAGM Special Business
21st Nov 20193:49 pmRNSResult of AGM
21st Nov 20197:00 amRNSScheduled Trading Update
15th Nov 20192:33 pmRNSHolding(s) in Company
14th Nov 20194:48 pmRNSHolding(s) in Company
14th Nov 20193:13 pmRNSHolding(s) in Company
11th Nov 20192:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.